{"transactions":[{"id":1023261,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-06T22:15:31.000Z","date":"2025-10-02","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16741,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 2, 2025, NH Holdings 2025, Inc. (\"Parent\"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and NH Holdings Acquisition 2025, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), dated as of December 23, 2024 (the \"Merger Agreement\"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the \"Merger\"). Parent and Merger Sub are indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Rollover Agreement, dated as of August 14, 2025 (the \"Rollover Agreement\"), entered into by and among NH Holdings 2025 SPV, L.P. (\"Holdings\"), NH Holdings 2025, Inc., NH Holdings Acquisition 2025, Inc. and the Reporting Person, the Reporting Person contributed its shares of Issuer common stock, Series A Convertible Perpetual Preferred Stock (\"Series A Preferred Stock\") and Series B Convertible Perpetual Preferred Stock (\"Series B Preferred Stock\") to Holdings in exchange for Holdings common units, series A preferred units and series B preferred units on a one for one basis in accordance with the Rollover Agreement, and effective as of the effective time of the Merger (the \"Effective Time\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001628280-25-044372","document":"wk-form4_1759788928.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000162828025044372/wk-form4_1759788928.xml","form_type":"4"}},{"id":1147328,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-15T22:15:20.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":false,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of these restricted stock units vested on May 13, 2025, one year from the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"All of these restricted stock units vested on May 13, 2025, one year from the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001628280-25-026084","document":"wk-form4_1747347313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000162828025026084/wk-form4_1747347313.xml","form_type":"4"}},{"id":1147327,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-15T22:15:20.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16741,"source":{"system":"sec-edgar","filing":"0001628280-25-026084","document":"wk-form4_1747347313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000162828025026084/wk-form4_1747347313.xml","form_type":"4"}},{"id":1517544,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-15T01:09:32.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of these restricted stock units vest on May 13, 2025, one year from the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All of these restricted stock units vest on May 13, 2025, one year from the grant date."}],"balance_after":10500,"derivative":{"underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001628280-24-023357","document":"wk-form4_1715735353.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000162828024023357/wk-form4_1715735353.xml","form_type":"4"}},{"id":1517543,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-15T01:09:32.000Z","date":"2024-05-12","kind":"exercise","planned":false,"acquired":false,"shares":4755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of these restricted stock units vested on May 12, 2024, one year from the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"All of these restricted stock units vested on May 12, 2024, one year from the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4755},"source":{"system":"sec-edgar","filing":"0001628280-24-023357","document":"wk-form4_1715735353.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000162828024023357/wk-form4_1715735353.xml","form_type":"4"}},{"id":1517542,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-15T01:09:32.000Z","date":"2024-05-12","kind":"exercise","planned":false,"acquired":true,"shares":4755,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6241,"source":{"system":"sec-edgar","filing":"0001628280-24-023357","document":"wk-form4_1715735353.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000162828024023357/wk-form4_1715735353.xml","form_type":"4"}},{"id":1891549,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-17T00:20:11.000Z","date":"2023-05-12","kind":"grant","planned":false,"acquired":true,"shares":380434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the restricted stock units vest on May 12, 2024, one year from the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"All of the restricted stock units vest on May 12, 2024, one year from the grant date."}],"balance_after":380434,"derivative":{"underlying":"Common Stock","underlying_shares":380434},"source":{"system":"sec-edgar","filing":"0001628280-23-018526","document":"wf-form4_168428279652807.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000162828023018526/wf-form4_168428279652807.xml","form_type":"4"}},{"id":1891548,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-17T00:20:11.000Z","date":"2023-05-13","kind":"exercise","planned":false,"acquired":false,"shares":118886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the restricted stock units vested on May 13, 2023, one year from the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"All of the restricted stock units vested on May 13, 2023, one year from the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":118886},"source":{"system":"sec-edgar","filing":"0001628280-23-018526","document":"wf-form4_168428279652807.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000162828023018526/wf-form4_168428279652807.xml","form_type":"4"}},{"id":1891547,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-17T00:20:11.000Z","date":"2023-05-13","kind":"exercise","planned":false,"acquired":true,"shares":118886,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":118886,"source":{"system":"sec-edgar","filing":"0001628280-23-018526","document":"wf-form4_168428279652807.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000162828023018526/wf-form4_168428279652807.xml","form_type":"4"}},{"id":2268164,"issuer":{"id":74308,"kind":"organization","name":"NeueHealth, Inc.","symbol":"NEUE"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-18T01:15:05.000Z","date":"2022-05-13","kind":"grant","acquired":true,"shares":118886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest one year from the date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest one year from the date of the grant."}],"balance_after":118886,"derivative":{"underlying":"Common Stock","underlying_shares":118886},"source":{"system":"sec-edgar","filing":"0001415889-22-005194","document":"form4-05172022_060522.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671284/000141588922005194/form4-05172022_060522.xml","form_type":"4"}},{"id":2498386,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"Pres, Government and Solutions"}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-11-23T23:01:01.000Z","date":"2021-11-19","kind":"tax_withholding","acquired":false,"shares":1081,"price":213.65,"value":230955.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax obligations upon vesting of restricted shares."}],"balance_after":43488,"source":{"system":"sec-edgar","filing":"0001225208-21-014116","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520821014116/doc4.xml","form_type":"4"}},{"id":2820722,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"Pres, Government and Solutions"}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-03-03T01:27:38.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":3087,"price":212.37,"value":655586.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2020."}],"balance_after":44569,"source":{"system":"sec-edgar","filing":"0001225208-21-004365","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520821004365/doc4.xml","form_type":"4"}},{"id":2820721,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"Pres, Government and Solutions"}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-03-03T01:27:38.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":2270,"price":210.31,"value":477403.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares."}],"balance_after":47656,"source":{"system":"sec-edgar","filing":"0001225208-21-004365","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520821004365/doc4.xml","form_type":"4"}},{"id":2820720,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"Pres, Government and Solutions"}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-03-03T01:27:38.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":1072,"price":210.31,"value":225452.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax obligations upon vesting of restricted shares."}],"balance_after":49926,"source":{"system":"sec-edgar","filing":"0001225208-21-004365","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520821004365/doc4.xml","form_type":"4"}},{"id":2820719,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"Pres, Government and Solutions"}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-03-03T01:27:38.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":5357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2018-2020 three-year performance period.  The number of shares of common stock received was based upon actual performance against pre-established Company performance goals."}],"balance_after":50998,"source":{"system":"sec-edgar","filing":"0001225208-21-004365","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520821004365/doc4.xml","form_type":"4"}},{"id":2829900,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"Pres, Government and Solutions"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-27T01:22:27.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":24884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in three equal annual installments beginning March 1, 2022."}],"balance_after":24884,"derivative":{"exercise_price":213.8,"exercise_date":"2022-03-01","expiration_date":"2031-02-24","underlying":"Common Stock, $.01 Par Value","underlying_shares":24884},"source":{"system":"sec-edgar","filing":"0001225208-21-003974","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520821003974/doc4.xml","form_type":"4"}},{"id":2829899,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"Pres, Government and Solutions"}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-02-27T01:22:27.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":5219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted shares vest in three equal annual installments beginning March 1, 2022."}],"balance_after":45641,"source":{"system":"sec-edgar","filing":"0001225208-21-003974","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520821003974/doc4.xml","form_type":"4"}},{"id":2897867,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"Pres, Government and Solutions"}}],"security":"Common Stock, $.01 Par Value","published_at":"2021-01-25T23:40:27.000Z","date":"2021-01-21","kind":"sale","acquired":false,"shares":5596,"price":230.064,"value":1287438.144,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price of the shares sold.  The prices actually received ranged from $230.00 to $230.14 per share.  The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":40422,"source":{"system":"sec-edgar","filing":"0001225208-21-001113","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520821001113/doc4.xml","form_type":"4"}},{"id":3238430,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"President, Strategy & Solution"}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-03-03T01:46:46.000Z","date":"2020-03-02","kind":"sale","acquired":false,"shares":3969,"price":182.85,"value":725731.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2018."}],"balance_after":46018,"source":{"system":"sec-edgar","filing":"0001225208-20-003954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520820003954/doc4.xml","form_type":"4"}},{"id":3238429,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"President, Strategy & Solution"}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-03-03T01:46:46.000Z","date":"2020-02-28","kind":"tax_withholding","acquired":false,"shares":2336,"price":179.41,"value":419101.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares."}],"balance_after":49987,"source":{"system":"sec-edgar","filing":"0001225208-20-003954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520820003954/doc4.xml","form_type":"4"}},{"id":3238428,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"President, Strategy & Solution"}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-03-03T01:46:46.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":6305,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2017-2019 three-year performance period.  The number of shares of common stock received was based upon actual performance against pre-established Company performance goals."}],"balance_after":52323,"source":{"system":"sec-edgar","filing":"0001225208-20-003954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520820003954/doc4.xml","form_type":"4"}},{"id":3238427,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"President, Strategy & Solution"}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-03-03T01:46:46.000Z","date":"2020-02-27","kind":"tax_withholding","acquired":false,"shares":548,"price":185.76,"value":101796.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax obligations upon vesting of restricted shares."}],"balance_after":46018,"source":{"system":"sec-edgar","filing":"0001225208-20-003954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520820003954/doc4.xml","form_type":"4"}},{"id":3241406,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"President, Strategy & Solution"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-02-29T02:27:11.000Z","date":"2020-02-26","kind":"grant","acquired":true,"shares":18586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in three equal annual installments beginning February 26, 2021."}],"balance_after":18586,"derivative":{"exercise_price":192.02,"exercise_date":"2021-02-26","expiration_date":"2030-02-26","underlying":"Common Stock, $.01 Par Value","underlying_shares":18586},"source":{"system":"sec-edgar","filing":"0001225208-20-003810","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520820003810/doc4.xml","form_type":"4"}},{"id":3241405,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"President, Strategy & Solution"}}],"security":"Common Stock, $.01 Par Value","published_at":"2020-02-29T02:27:11.000Z","date":"2020-02-26","kind":"grant","acquired":true,"shares":5078,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted shares vests in three equal annual installments beginning February 26, 2021."}],"balance_after":46566,"source":{"system":"sec-edgar","filing":"0001225208-20-003810","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520820003810/doc4.xml","form_type":"4"}},{"id":3371434,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"President, Strategy & Solution"}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-11-14T22:36:23.000Z","date":"2019-11-12","kind":"gift","acquired":false,"shares":1605,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":41488,"source":{"system":"sec-edgar","filing":"0001225208-19-014503","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819014503/doc4.xml","form_type":"4"}},{"id":3608646,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"President, Strategy & Solution"}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-03-07T00:49:16.000Z","date":"2019-03-04","kind":"sale","acquired":false,"shares":4758,"price":178.98,"value":851586.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2018."}],"balance_after":43093,"source":{"system":"sec-edgar","filing":"0001225208-19-004831","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819004831/doc4.xml","form_type":"4"}},{"id":3613274,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"President, Strategy & Solution"}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-03-06T02:19:35.000Z","date":"2019-03-01","kind":"tax_withholding","acquired":false,"shares":2241,"price":177.85,"value":398561.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax obligations upon vesting."}],"balance_after":47851,"source":{"system":"sec-edgar","filing":"0001225208-19-004743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819004743/doc4.xml","form_type":"4"}},{"id":3613273,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"President, Strategy & Solution"}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-03-06T02:19:35.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":6999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2016-2018 three-year performance period.  The number of shares of common stock received was based upon actual performance against pre-established Company performance goals."}],"balance_after":50092,"source":{"system":"sec-edgar","filing":"0001225208-19-004743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819004743/doc4.xml","form_type":"4"}},{"id":3623393,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"President, Strategy & Solution"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-02T01:22:25.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":18360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in three equal annual installments beginning February 27, 2020."}],"balance_after":18360,"derivative":{"exercise_price":183.4405,"exercise_date":"2020-02-27","expiration_date":"2029-02-27","underlying":"Common Stock, $.01 Par Value","underlying_shares":18360},"source":{"system":"sec-edgar","filing":"0001225208-19-004244","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819004244/doc4.xml","form_type":"4"}},{"id":3623392,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"President, Strategy & Solution"}}],"security":"Common Stock, $.01 Par Value","published_at":"2019-03-02T01:22:25.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":5316,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted shares vest in three equal annual installments beginning February 27, 2020."}],"balance_after":43093,"source":{"system":"sec-edgar","filing":"0001225208-19-004244","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000122520819004244/doc4.xml","form_type":"4"}},{"id":3719219,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Strategy & Solution"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:15:55.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":28038,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":28038,"derivative":{"exercise_price":149.135,"expiration_date":"2027-02-28","underlying":"Common Stock, $0.01 Par Value","underlying_shares":28038},"source":{"system":"sec-edgar","filing":"0001567619-18-008702","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008702/doc1.xml","form_type":"4"}},{"id":3719218,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Strategy & Solution"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:15:55.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":34035,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":34035,"derivative":{"exercise_price":139.22,"expiration_date":"2026-03-01","underlying":"Common Stock, $0.01 Par Value","underlying_shares":34035},"source":{"system":"sec-edgar","filing":"0001567619-18-008702","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008702/doc1.xml","form_type":"4"}},{"id":3719217,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Strategy & Solution"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:15:55.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":30229,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":30229,"derivative":{"exercise_price":120.895,"expiration_date":"2025-02-25","underlying":"Common Stock, $0.01 Par Value","underlying_shares":30229},"source":{"system":"sec-edgar","filing":"0001567619-18-008702","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008702/doc1.xml","form_type":"4"}},{"id":3719216,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Strategy & Solution"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-27T00:15:55.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":39038,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":39038,"derivative":{"exercise_price":78.035,"expiration_date":"2024-02-26","underlying":"Common Stock, $0.01 Par Value","underlying_shares":39038},"source":{"system":"sec-edgar","filing":"0001567619-18-008702","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008702/doc1.xml","form_type":"4"}},{"id":3719215,"issuer":{"id":550,"kind":"organization","name":"Cigna Group","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Strategy & Solution"}}],"security":"Common Stock, $0.01 Par Value","published_at":"2018-12-27T00:15:55.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":37777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"shares","element":"transactionShares","label":"F3","text":"Includes 2,352 restricted shares acquired in the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common Stock of Cigna Corporation, f/k/a Halfmoon Parent, Inc. (\"New Cigna\"), was acquired pursuant to the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (continued in following footnote)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from previous footnote) (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, with Express Scripts surviving as a wholly owned subsidiary of New Cigna.  As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna.  In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\").  The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."}],"balance_after":37777,"source":{"system":"sec-edgar","filing":"0001567619-18-008702","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739940/000156761918008702/doc1.xml","form_type":"4"}},{"id":3720422,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Strategy & Solution"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-26T18:48:14.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":28038,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects disposition in connection with the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":149.135,"expiration_date":"2027-02-28","underlying":"Common Stock, $.25 Par Value","underlying_shares":28038},"source":{"system":"sec-edgar","filing":"0001567619-18-008665","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/701221/000156761918008665/doc1.xml","form_type":"4"}},{"id":3720421,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Strategy & Solution"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-26T18:48:14.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":34035,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects disposition in connection with the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":139.22,"expiration_date":"2026-03-01","underlying":"Common Stock, $.25 Par Value","underlying_shares":34035},"source":{"system":"sec-edgar","filing":"0001567619-18-008665","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/701221/000156761918008665/doc1.xml","form_type":"4"}},{"id":3720420,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Strategy & Solution"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-26T18:48:14.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":30229,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects disposition in connection with the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":120.895,"expiration_date":"2025-02-25","underlying":"Common Stock, $.25 Par Value","underlying_shares":30229},"source":{"system":"sec-edgar","filing":"0001567619-18-008665","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/701221/000156761918008665/doc1.xml","form_type":"4"}},{"id":3720419,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Strategy & Solution"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-26T18:48:14.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":39038,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects disposition in connection with the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the terms of the Merger Agreement, each stock option of Cigna outstanding immediately prior to the Effective Time (whether vested or unvested) was automatically converted into an option to purchase shares of New Cigna Common Stock equal to the total number of shares of Cigna Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was fully vested and exercisable at the time of the Merger."}],"balance_after":0,"derivative":{"exercise_price":78.035,"expiration_date":"2024-02-26","underlying":"Common Stock, $.25 Par Value","underlying_shares":39038},"source":{"system":"sec-edgar","filing":"0001567619-18-008665","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/701221/000156761918008665/doc1.xml","form_type":"4"}},{"id":3720418,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Strategy & Solution"}}],"security":"Common Stock, $.25 Par Value","published_at":"2018-12-26T18:48:14.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":37777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects disposition in connection with the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, (continued in following footnote)"},{"field":"kind","element":"transactionCoding","label":"F2","text":"(continued from previous footnote) with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."},{"field":"shares","element":"transactionShares","label":"F5","text":"Includes 2,352 restricted shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition in connection with the consummation of the mergers (collectively, the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 8, 2018, as amended by Amendment No. 1, dated as of June 27, 2018, by and among Cigna Corporation (now known as Cigna Holding Company) (\"Cigna\"), Express Scripts Holding Company (\"Express Scripts\"), Halfmoon Parent, Inc. (now known as Cigna Corporation), a direct wholly owned subsidiary of Cigna prior to the Merger (\"New Cigna\"), Halfmoon I, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger, and Halfmoon II, Inc., a direct wholly owned subsidiary of New Cigna prior to the Merger (the \"Merger Agreement\"), pursuant to which, at the effective time of the Merger (the \"Effective Time\"), (1) Halfmoon I, Inc. merged with and into Cigna, with Cigna surviving as a wholly owned subsidiary of New Cigna, and (2) Halfmoon II, Inc. merged with and into Express Scripts, (continued in following footnote)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from previous footnote) with Express Scripts surviving as a wholly owned subsidiary of New Cigna. As a result of the transactions contemplated by the Merger Agreement, New Cigna became a publicly traded corporation, and former Cigna stockholders and former Express Scripts stockholders now own common stock of New Cigna. In the Merger, each share of Cigna common stock, par value $0.25 per share (\"Cigna Common Stock\"), was exchanged for one share of common stock, par value $0.01 per share, of New Cigna (\"New Cigna Common Stock\"). The closing price per share of Cigna Common Stock on December 19, 2018 (the last trading day prior to the date of the Effective Time) was $193.30."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-18-008665","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/701221/000156761918008665/doc1.xml","form_type":"4"}},{"id":3758066,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"President, Strategy & Solution"}}],"security":"Common Stock, $.25 Par Value","published_at":"2018-11-20T19:27:21.000Z","date":"2018-11-19","kind":"grant","acquired":true,"shares":2352,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":37777,"source":{"system":"sec-edgar","filing":"0001225208-18-015752","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520818015752/doc4.xml","form_type":"4"}},{"id":4252987,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"Pres. Gov't & Ind Prog & Group"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-07-24T17:36:54.000Z","date":"2017-07-24","kind":"exercise","acquired":false,"shares":5596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on February 28, 2012.  The option vested in three equal annual installments on the first, second and third anniversaries of the grant date."}],"balance_after":0,"derivative":{"exercise_price":44.425,"exercise_date":"2013-02-28","expiration_date":"2022-02-28","underlying":"Common Stock, $.25 Par Value","underlying_shares":5596},"source":{"system":"sec-edgar","filing":"0001225208-17-012827","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520817012827/doc4.xml","form_type":"4"}},{"id":4252986,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"Pres. Gov't & Ind Prog & Group"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-07-24T17:36:54.000Z","date":"2017-07-21","kind":"exercise","acquired":false,"shares":11900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on February 28, 2012.  The option vested in three equal annual installments on the first, second and third anniversaries of the grant date."}],"balance_after":5596,"derivative":{"exercise_price":44.425,"exercise_date":"2013-02-28","expiration_date":"2022-02-28","underlying":"Common Stock, $.25 Par Value","underlying_shares":11900},"source":{"system":"sec-edgar","filing":"0001225208-17-012827","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520817012827/doc4.xml","form_type":"4"}},{"id":4252985,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"Pres. Gov't & Ind Prog & Group"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-07-24T17:36:54.000Z","date":"2017-07-20","kind":"exercise","acquired":false,"shares":12457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on February 28, 2012.  The option vested in three equal annual installments on the first, second and third anniversaries of the grant date."}],"balance_after":17496,"derivative":{"exercise_price":44.425,"exercise_date":"2013-02-28","expiration_date":"2022-02-28","underlying":"Common Stock, $.25 Par Value","underlying_shares":12457},"source":{"system":"sec-edgar","filing":"0001225208-17-012827","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520817012827/doc4.xml","form_type":"4"}},{"id":4252984,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"Pres. Gov't & Ind Prog & Group"}}],"security":"Common Stock, $.25 Par Value","published_at":"2017-07-24T17:36:54.000Z","date":"2017-07-24","kind":"exercise","acquired":true,"shares":5596,"price":44.425,"value":248602.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017."}],"balance_after":39395,"source":{"system":"sec-edgar","filing":"0001225208-17-012827","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520817012827/doc4.xml","form_type":"4"}},{"id":4252983,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"Pres. Gov't & Ind Prog & Group"}}],"security":"Common Stock, $.25 Par Value","published_at":"2017-07-24T17:36:54.000Z","date":"2017-07-21","kind":"sale","acquired":false,"shares":11900,"price":175.0139,"value":2082665.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average price of the shares sold.  The prices actually received ranged from $175.00 to $175.06 per share.  The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":33799,"source":{"system":"sec-edgar","filing":"0001225208-17-012827","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520817012827/doc4.xml","form_type":"4"}},{"id":4252982,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"Pres. Gov't & Ind Prog & Group"}}],"security":"Common Stock, $.25 Par Value","published_at":"2017-07-24T17:36:54.000Z","date":"2017-07-21","kind":"exercise","acquired":true,"shares":11900,"price":44.425,"value":528657.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017."}],"balance_after":45699,"source":{"system":"sec-edgar","filing":"0001225208-17-012827","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520817012827/doc4.xml","form_type":"4"}},{"id":4252981,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"Pres. Gov't & Ind Prog & Group"}}],"security":"Common Stock, $.25 Par Value","published_at":"2017-07-24T17:36:54.000Z","date":"2017-07-20","kind":"sale","acquired":false,"shares":12457,"price":175.007,"value":2180062.199,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average price of the shares sold.  The prices actually received ranged from $175.00 to $175.01 per share.  The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":33799,"source":{"system":"sec-edgar","filing":"0001225208-17-012827","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520817012827/doc4.xml","form_type":"4"}},{"id":4252980,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"Pres. Gov't & Ind Prog & Group"}}],"security":"Common Stock, $.25 Par Value","published_at":"2017-07-24T17:36:54.000Z","date":"2017-07-20","kind":"exercise","acquired":true,"shares":12457,"price":44.425,"value":553402.225,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017."}],"balance_after":46256,"source":{"system":"sec-edgar","filing":"0001225208-17-012827","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520817012827/doc4.xml","form_type":"4"}},{"id":4291969,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"Pres. Gov't & Ind Prog & Group"}}],"security":"Common Stock, $.25 Par Value","published_at":"2017-06-06T17:44:43.000Z","date":"2017-06-02","kind":"sale","acquired":false,"shares":6000,"price":165,"value":990000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017."}],"balance_after":33799,"source":{"system":"sec-edgar","filing":"0001225208-17-010977","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520817010977/doc4.xml","form_type":"4"}},{"id":4412179,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"Pres. Gov't & Ind Prog & Group"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-03-02T17:48:41.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":28038,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in three equal annual installments beginning February 28, 2018."}],"balance_after":28038,"derivative":{"exercise_price":149.135,"exercise_date":"2018-02-28","expiration_date":"2027-02-28","underlying":"Common Stock, $.25 Par Value","underlying_shares":28038},"source":{"system":"sec-edgar","filing":"0001225208-17-005400","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520817005400/doc4.xml","form_type":"4"}},{"id":4415910,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"Pres. Gov't & Ind Prog & Group"}}],"security":"Common Stock, $.25 Par Value","published_at":"2017-03-01T17:54:25.000Z","date":"2017-02-27","kind":"sale","acquired":false,"shares":8309,"price":146.54,"value":1217600.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016."}],"balance_after":39799,"source":{"system":"sec-edgar","filing":"0001225208-17-005117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520817005117/doc4.xml","form_type":"4"}},{"id":4419723,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"Pres. Gov't & Ind Prog & Group"}}],"security":"Common Stock, $.25 Par Value","published_at":"2017-02-28T18:47:12.000Z","date":"2017-02-24","kind":"tax_withholding","acquired":false,"shares":8290,"price":147.08,"value":1219293.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax obligations upon vesting."}],"balance_after":48108,"source":{"system":"sec-edgar","filing":"0001225208-17-004976","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520817004976/doc4.xml","form_type":"4"}},{"id":4419722,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"Pres. Gov't & Ind Prog & Group"}}],"security":"Common Stock, $.25 Par Value","published_at":"2017-02-28T18:47:12.000Z","date":"2017-02-24","kind":"grant","acquired":true,"shares":16599,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2014-2016 three-year performance period.  The number of shares of common stock received was based upon actual performance against pre-established Company performance goals."}],"balance_after":56398,"source":{"system":"sec-edgar","filing":"0001225208-17-004976","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520817004976/doc4.xml","form_type":"4"}},{"id":4458401,"issuer":{"id":161580,"kind":"organization","name":"Cigna Holding Co","symbol":"CI"},"owners":[{"id":74502,"kind":"person","name":"Manders Matthew G","position":1,"cik":"0001480601","reported_name":"Manders Matthew G","relationship":{"officer":true,"officer_title":"Pres. US Comm Mkts & Gbl HC Op"}}],"security":"Common Stock, $.25 Par Value","published_at":"2017-02-10T18:12:32.000Z","date":"2016-11-14","kind":"gift","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016."}],"balance_after":39799,"source":{"system":"sec-edgar","filing":"0001225208-17-002825","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/701221/000122520817002825/doc5.xml","form_type":"5"}}]}